|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 10:43AM
|
|
Re: Resverlogix BIO CEO & Investor Conference 2017 Slides
|
2
|
Resverlogix Corp.
|
Feb 14, 2017 02:08PM
|
|
Re: Resverlogix BIO CEO & Investor Conference 2017 Slides
|
2
|
Resverlogix Corp.
|
Feb 15, 2017 11:46AM
|
|
Re: Resverlogix BIO CEO & Investor Conference 2017 Slides
|
1
|
Resverlogix Corp.
|
Feb 15, 2017 01:49PM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
4
|
Resverlogix Corp.
|
Apr 01, 2019 11:12AM
|
|
Re: Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Sep 14, 2018 09:45AM
|
|
Re: Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Sep 14, 2018 06:45PM
|
|
Re: Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders
|
6
|
Resverlogix Corp.
|
Sep 14, 2018 06:50PM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
4
|
Resverlogix Corp.
|
Apr 11, 2018 08:33AM
|
|
Re: Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conferenc
|
4
|
Resverlogix Corp.
|
Jul 17, 2018 10:23AM
|
|
Re: Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conferenc
|
3
|
Resverlogix Corp.
|
Jul 17, 2018 02:49PM
|
|
Re: Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
|
5
|
Resverlogix Corp.
|
Mar 28, 2018 07:34AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
4
|
Resverlogix Corp.
|
Sep 30, 2019 10:11AM
|
|
Re: Resverlogix Announces Third Positive Recommendation From DSMB For Phase 3 BETonMACE
|
2
|
Resverlogix Corp.
|
Mar 17, 2017 08:47AM
|
|
Re: Resverlogix Announces Successful Phase 1 Renal Trial Results...
|
2
|
Resverlogix Corp.
|
Nov 17, 2016 08:34AM
|
|
Re: Resverlogix Announces Successful Phase 1 Renal Trial Results...
|
3
|
Resverlogix Corp.
|
Nov 17, 2016 09:56AM
|
|
Re: Resverlogix Announces Successful Phase 1 Renal Trial Results...
|
3
|
Resverlogix Corp.
|
Nov 17, 2016 11:02AM
|
|
Re: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
8
|
Resverlogix Corp.
|
Aug 07, 2018 12:04PM
|
|
Re: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
4
|
Resverlogix Corp.
|
Aug 07, 2018 07:21AM
|
|
Re: Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
|
3
|
Resverlogix Corp.
|
Mar 15, 2017 09:16AM
|
